NEFECON TREATMENT PROVIDES KIDNEY BENEFITS FOR PATIENTS WITH IgAN THAT EXTEND TO THOSE WITH LOW LEVELS OF UPCR: A SUB-ANALYSIS OF THE PHASE III NefIgArd TRIAL

  Back

14 Apr 2024 5:45 p.m. 6:45 p.m.

WCN24-AB-1777, Poster Board= SUN-034

Jonathan Barratt Poster Presenter